Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
Phase of Trial: Phase I/II
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Sitagliptin (Primary) ; Insulin
- Indications Latent autoimmune diabetes in adults
- Focus Pharmacodynamics
- 16 Jan 2014 Results published in the Journal of Clinical Endocrinology and Metabolism.
- 30 Sep 2013 Status changed from recruiting to completed.
- 25 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.